Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call

Core Points - Zevra Therapeutics, Inc. will report its corporate and financial results for Q2 2025 on August 12, 2025, after market close, followed by a conference call at 4:30 p.m. ET [1] - The audio webcast of the conference call will be available on Zevra's Investor Relations website, with a replay accessible for 90 days [2] - Zevra is a commercial-stage company focused on developing therapies for rare diseases, aiming to provide life-changing treatments where options are limited or nonexistent [3] Company Overview - Zevra Therapeutics combines science, data, and patient needs to create transformational therapies for rare diseases [3] - The company employs unique, data-driven strategies for drug development and commercialization to address complex challenges in making new therapies available [3]